Related Experiment Videos
Iris-claw lens in phakic eyes to correct hyperopia: preliminary study
P U Fechner1, D Singh, K Wulff
1Robert Koch Hospital, Hannover-Gehrden, Germany.
Journal of Cataract and Refractive Surgery
|March 12, 1998
Summary
Implanting convex, iris-fixated, anterior chamber intraocular lenses (IOLs) in phakic eyes effectively corrects high hyperopia. While refractive outcomes are successful, long-term endothelial microscopy is crucial for monitoring clinical risks.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Refractive Error Correction
Background:
- High hyperopia presents a significant challenge for vision correction.
- Phakic intraocular lenses (IOLs) offer a potential solution for refractive errors.
- Iris-fixated anterior chamber IOLs are an option for specific patient groups.
Purpose of the Study:
- To assess the efficacy and safety of convex, iris-fixated, anterior chamber IOLs in phakic eyes.
- To evaluate the refractive outcomes and potential complications associated with this IOL type.
- To determine the long-term results of this surgical approach for high hyperopia.
Main Methods:
- A retrospective study involving two centers: Robert Koch Hospital (Germany) and Dr. Daljit Singh Eye Hospital (India).
- Implantation of convex, iris-fixated, anterior chamber IOLs in 69 phakic eyes (2 at Center A, 67 at Center B).
- Follow-up durations varied: 91 months for Center A, mean 78 months (range 12-120 months) for Center B.
Main Results:
- Successful refractive correction of high hyperopia was achieved in most cases.
- At Center B, corneas remained clear, and no iritis or glaucoma was observed in the majority of eyes.
- One patient experienced complications including glaucoma and corneal degeneration, attributed to inadequate postoperative care due to late follow-up.
Conclusions:
- Convex iris-claw lens implantation in the anterior chamber of phakic eyes is a successful refractive procedure for high hyperopia.
- The clinical risks associated with this IOL implantation appear manageable.
- Mandatory lifelong monitoring using endothelial microscopy is essential to manage potential long-term complications.